About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Targeted Therapy Kills Gene Vulnerable Cancer Cells Effectively

by Angela Mohan on November 23, 2020 at 4:44 PM
Font : A-A+

Targeted Therapy Kills Gene Vulnerable Cancer Cells Effectively

Small-molecule enolase inhibitor found to be effective in killing brain cancer cells that were missing ENO1, one of two genes encoding the enolase enzyme, as per the study by the team of researchers at the University of Texas MD Anderson Cancer Center, published in Nature Metabolism.

The new study provide the concept of collateral lethality, in which a vital protein is lost through genetic deletion as a bystander near a tumor suppressor gene, and a redundant protein is blocked therapeutically.

Advertisement


"Collateral lethality could expand the scope of precision oncology beyond activated oncogenes, and allow targeting of genomic deletions, largely considered un-actionable," said corresponding author Florian Muller, Ph.D., assistant professor of Cancer Systems Imaging and Neuro-Oncology.

"Our work provides proof of principle that this approach can actually work with a drug in animal models."

Enolase encoding genes ENO1 and ENO2, encode slightly different. Targeting only ENO2 is attractive as it allows for the selective treatment of cancer cells missing ENO1.
Advertisement

The research team worked to generate an enolase inhibitor, called HEX, that targets ENO2 over ENO1. Prodrug POMHEX was developed, which is biologically inactive until it is metabolized into HEX within cells.

Treatment with POMHEX blocked glycolysis, inhibited cell growth and stimulated cell death. Conversely, treatment of cells with normal ENO1 showed minimal effects. Further, in animal models of ENO1-deficient tumors, both HEX and POMHEX treatment was well- tolerated and effectively blocked tumor growth relative to controls, with some instances of complete tumor eradication.

Taking the work one step further, the team demonstrated that the best effective dose could be safely given in multiple models, suggesting favorable future translation to the clinical studies.

"We were encouraged by the promising preclinical activity of these novel enolase inhibitors and that the safety profile extends to higher models. While there could be further refinements, I am optimistic that even HEX would show significant clinical activity against ENO1-deleted cancers," Muller said.

ENO1 deletions also occur in liver cancer, bile duct cancer and large-cell neuroendocrine lung cancers, all of which share poor prognosis and limited treatment options, Muller explained. Thus, once an optimal therapy candidate has been developed, there is potential to evaluate the ENO2 inhibitor in treating patients with multiple cancer types.



Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Cervical Cancer Awareness Month 2022
Ultra-Low-Fat Diet
Goji Berries May Protect Against Age-Related Vision Loss
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
DNA Finger Printing Cancer and Homeopathy Parkinsons Disease Surgical Treatment Colorectal Cancer Reiki and Pranic Healing Cancer Facts Cancer Tattoos A Body Art Weaver Syndrome Common Lifestyle Habits that Cause Diseases 

Recommended Reading
New Targeted Therapies Help Decrease Lung Fibrosis
Purdue University scientists developed a new treatment option for lung fibrosis. Lung fibrosis has ....
Colorectal Cancer
Colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancer is the third...
Common Lifestyle Habits that Cause Diseases
Cigarette smoking, unhealthy diets, overuse of alcohol, and physical inactivity are some of the most...
DNA Finger Printing
DNA fingerprinting is a technique which helps forensic scientists and legal experts solve crimes, id...
Tattoos A Body Art
Tattoos are a rage among college students who sport it for the ‘cool dude’ or ‘cool babe’ look...
Weaver Syndrome
Weaver syndrome is a genetic disorder in which children show accelerated bone growth, advanced bone ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT A DOCTOR
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)